Brief: Epsilon Healthcare Signs Clinical Trial Supply Agreement With MCRI
09/06/2021 24:51
June 9 (Reuters) - Epsilon Healthcare Ltd EPN.AX :
* EPSILON HEALTHCARE ANNOUNCES CLINICAL TRIAL SUPPLY
AGREEMENT
WITH MCRI
* SUPPLYING STUDY DRUG FOR CLINICAL STUDY OF BEHAVIOURAL
PROBLEMS
IN INTELLECTUAL DISABILITIES
* CLINICAL STUDY WILL BE CONDUCTED BY MURDOCH CHILDREN'S
RESEARCH
INSTITUTE USING CANNABIDIOL MEDICINES
Source text for Eikon: ID:nASX819zXY
Further company coverage: EPN.AX
((reuters.briefs@thomsonreuters.com))
Recent news on Epsilon Healthcare
See all newsBrief: Epsilon Healthcare Partners With Helix And Puro
Brief: Epsilon Healthcare Terminates Promissory Note With Lekarna
Brief: Epsilon Healthcare Announces Small Holding Share Sale Facility At A$0.02 Per Share
Brief: Epsilon Healthcare Reports Qtrly Revenue A$3.3 Mln
Brief: Epsilon Healthcare Says Settled Proceedings With Former Director Josh (Xiao) Cui And Watercrest Capital